Opioid Use Disorder
UK HealthCare has been serving Lexington and its surrounding communities since 1962. Home to a Level I Trauma Center and a Level IV Neonatal Intensive Care Unit, UK HealthCare is committed to ensuring that every Kentuckian, no matter how sick they are, has access to quality care.
The legal principles discussed also apply to individuals with other types of substance use disorders.
In this webinar, Hazelden Betty Ford’s Stephen Delisi, MD, will examine the growing rates of substance use disorder and the impact of opioids and fentanyl on communities through his role consulting with health systems and medical professionals across the country. To focus on one health system’s…
AHA letter to Representative Donald Norcross expressing support for bipartisan legislation, the Opioid Treatment Access Act (H.R. 6279).
Nearly three-fourths of the 2.4 million U.S. adults who reported using buprenorphine in 2019 did not misuse the medication in the past 12 months, according to a National Institutes of Health study released in JAMA Network Open.
Strategies for opioid stewardship. This Transformation Talks video explores steps providers can take to help address the opioid crisis.
Access to behavioral health care unfortunately remains difficult due to the shortage of providers, stigma, lack of a true connected continuum of care, and more. This series of case studies featuring the innovative work of hospitals and health systems and their community partners, details how…
This webinar is presented by:Sarah E. Wakeman, MDMedical Director, Massachusetts General Hospital Substance Use Disorder InitiativeMedical Director, Massachusetts General Hospital Addiction Consult TeamDirector, Addiction Medicine Fellowship ProgramAssociate Professor of Medicine, Harvard Medical…
Hospital outpatient departments, critical access hospitals, rural health clinics and other eligible providers may apply through Jan. 3 to participate in the Value in Opioid Use Disorder Treatment demonstration.
The Drug Enforcement Administration published an interim final rule expanding access to medication-assisted treatment under the SUPPORT for Patients and Communities Act of 2018.